Cornerstone Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$16.3M	Buy	36,600 +23,600	+182%	+$10.5M	0.56%	47
2025 Q1	$6.3M	Hold	13,000	–	–	0.27%	93
2024 Q4	$5.24M	Hold	13,000	–	–	0.21%	108
2024 Q3	$6.05M	Buy	13,000 +800	+7%	+$372K	0.24%	103
2024 Q2	$5.72M	Sell	12,200 -100	-0.8%	-$46.9K	0.23%	107
2024 Q1	$5.14M	Hold	12,300	–	–	0.21%	119
2023 Q4	$5M	Sell	12,300 -4,800	-28%	-$1.95M	0.22%	117
2023 Q3	$5.95M	Sell	17,100 -6,200	-27%	-$2.16M	0.28%	102
2023 Q2	$8.2M	Buy	23,300 +3,300	+17%	+$1.16M	0.39%	71
2023 Q1	$6.3M	Hold	20,000	–	–	0.29%	82
2022 Q4	$5.78M	Sell	20,000 -7,000	-26%	-$2.02M	0.29%	93
2022 Q3	$7.82M	Hold	27,000	–	–	0.38%	73
2022 Q2	$7.61M	Buy	27,000 +5,000	+23%	+$1.41M	0.4%	70
2022 Q1	$5.74M	Hold	22,000	–	–	0.34%	77
2021 Q4	$4.83M	Hold	22,000	–	–	0.26%	95
2021 Q3	$3.99M	Hold	22,000	–	–	0.23%	112
2021 Q2	$4.44M	Buy	22,000 +9,000	+69%	+$1.81M	0.26%	104
2021 Q1	$2.79M	Sell	13,000 -7,000	-35%	-$1.5M	0.24%	102
2020 Q4	$4.73M	Hold	20,000	–	–	0.41%	58
2020 Q3	$5.44M	Hold	20,000	–	–	0.49%	50
2020 Q2	$5.81M	Buy	20,000 +7,000	+54%	+$2.03M	0.54%	44
2020 Q1	$3.09M	Buy	+13,000	New	+$3.09M	0.34%	72
2018 Q4	–	Sell	-9,000	Closed	-$1.74M	–	253
2018 Q3	$1.74M	Hold	9,000	–	–	0.13%	168
2018 Q2	$1.53M	Hold	9,000	–	–	0.19%	129
2018 Q1	$1.47M	Sell	9,000 -5,000	-36%	-$815K	0.17%	144
2017 Q4	$2.1M	Hold	14,000	–	–	0.24%	117
2017 Q3	$2.13M	Buy	14,000 +9,000	+180%	+$1.37M	0.25%	118
2017 Q2	$644K	Buy	+5,000	New	+$644K	0.12%	175